Goldman Sachs Upgrades Allstate to Neutral (ALL)
A number of other firms have also recently commented on ALL. Analysts at Barclays Capital (NYSE: BCS) raised their price target on shares of Allstate from $29.00 to $32.00 in a research note to investors on Monday, April 2nd. They now have an “equal weight” rating on the stock. Separately, analysts at UBS AG (NYSE: UBS) raised their EPS on shares of Allstate in a research note to investors on Wednesday, March 14th. They now have a “buy” rating and a $37.00 price target on the stock. They previously had a $35.00 price target on the stock. Finally, analysts at Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research note to investors on Monday, March 5th. They now have a $36.00 price target on the stock.
Allstate traded down 0.09% on Thursday, hitting $34.20. Allstate has a 52-week low of $22.27 and a 52-week high of $34.83. The company has a market cap of $16.805 billion and a price-to-earnings ratio of 17.05.
The company last announced its quarterly results on Wednesday, May 2nd. It reported $1.53 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $1.10 EPS by $0.43. The company’s quarterly revenue was up 2.8% on a year-over-year basis. Analysts expect that Allstate will post $0.74 EPS next quarter.
The Allstate Corporation (Allstate), incorporated on November 5, 1992, is a holding company of Allstate Insurance Company.